80 FR 73830 - Importer of Controlled Substances Application: VHG Labs DBA LGC Standards Warehouse
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 80, Issue 227 (November 25, 2015)
Drug Enforcement Administration
Federal Register Volume 80, Issue 227 (November 25, 2015)
| Page Range | 73830-73833 | |
| FR Document | 2015-29934 |
[Federal Register Volume 80, Number 227 (Wednesday, November 25, 2015)] [Notices] [Pages 73830-73833] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-29934] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: VHG Labs DBA LGC Standards Warehouse ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before December 28, 2015. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before December 28, 2015. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (``Deputy Assistant Administrator'') pursuant to section. 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on December 03, 2014, VHG Labs DBA LGC Standards Warehouse, 3 Perimeter Road, Manchester, New Hampshire 03103 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC) (1233)........ I Cathinone (1235)................................. I Methcathinone (1237)............................. I 4-Fluoro-N-methylcathinone (4-FMC) (1238)........ I Pentedrone (a-methylaminovalerophenone) (1246)... I Mephedrone (4-Methyl-N-methylcathinone) (1248)... I 4-Methyl-N-ethylcathinone (4-MEC) (1249)......... I Naphyrone (1258)................................. I N-Ethylamphetamine (1475)........................ I N,N-Dimethylamphetamine (1480)................... I Fenethylline (1503).............................. I 4-Methylaminorex (cis isomer) (1590)............. I Gamma Hydroxybutyric Acid (2010)................. I Methaqualone (2565).............................. I Mecloqualone (2572).............................. I JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) I indole) (6250). SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3- I (2-methoxyphenylacetyl) Indole) (7008). 5-Fluoro-UR-144 and XLR11 [1-(5-Flouro-pentyl)-1H- I indol-3-yl] (2,2,3,3-tetramethylcyclopropyl) methanone (7011). AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl) I -1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) (7012). JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) (7019)... I ADB-PINACA (N-1-amino-3,3-dimethyl-1-oxobutan-2- I yl)-1-pentyl-1H-indazole-3-carboxamide) (7035). APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H- I indazole-3-carboxamide (7048). [[Page 73831]] JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) I Indole) (7081). SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- I methoxy)-benzoyl] indole (7104). JWH-018 (also known as AM678) (1-Pentyl-3-(1- I naphthoyl)indole) (7118). JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)Indole) I (7122). UR-144 (1-Pentyl-1H-indol-3-yl) (2,2,3,3- I tetramethylcyclopropyl) methanone (7144). JWH-073 (1-Butyl-3-(1-naphthoyl)indole) (7173)... I JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- I naphthoyl)indole) (7200). AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) I Indole) (7201). JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)Indole) I (7203). PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- I carboxylate) (7222). 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H- I indole-3-carboxylate) (7225). Alpha-ethyltryptamine (7249)..................... I Ibogaine (7260).................................. I CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- I hydroxycyclohexyl-phenol) (7297). CP-47497 C8 Homologue (5-(1,1-Dimethyloctyl)-2- I [(1R,3S)3-hydroxycyclohexyl-phenol) (7298). Lysergic acid diethylamide (7315)................ I 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C- I T-7) (7348). Marihuana (7360)................................. I Tetrahydrocannabinols (7370)..................... I Parahexyl (7374)................................. I Mescaline (7381)................................. I 2-(4-Elthylthio-2,5-dimethoxyphenyl) ethanamine I (2C-T-2) (7385). 3,4,5-Trimethoxyamphetamine (7390)............... I 4-Bromo-2,5-dimethoxyamphetamine (7391).......... I 4-Bromo-2,5-dimethoxyphenethylamine (7392)....... I 4-Methyl-2,5-dimethoxyamphetamine (7395)......... I 2,5-Dimethoxyamphetamine (7396).................. I JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)Indole I (7398). 2,5-Dimethoxy-4-ethylamphetamine (7399).......... I 3,4-Methylenedioxyamphetamine (7400)............. I 5-Methoxy-3,4-methylenedioxyamphetamine (7401)... I N-Hydroxy-3,4-methylenedioxyamphetaimine (7402).. I 3,4-Methylenedioxy-N-ethylamphetamine (7404)..... I 3,4-Methylenedioxymethamphetamine (7405)......... I 4-Methoxyamphetamine (7411)...................... I Peyote (7415).................................... I 5-Methoxy-N-N-dimethyltryptamine (7431).......... I Alpha-methyltryptamine (7432).................... I Bufotenine (7433)................................ I Diethyltryptamine (7434)......................... I Dimethyltryptamine (7435)........................ I Psilocybin (7437)................................ I Psilocyn (7438).................................. I 5-Methoxy-N,N-diisopropyltryptamine (7439)....... I N-Ethyl-1-phenylcyclohexylamine (7455)........... I 1-(1-Phenylcyclohexyl)pyrrolidine (7458)......... I 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)..... I 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (7473).... I N-Ethyl-3-piperidyl benzilate (7482)............. I N-Methyl-3-piperidyl benzilate (7484)............ I N-Benzylpiperazine (7493)........................ I 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) I (7498). 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C- I D) (7508). 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) I (7509). 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) (7517). I 2-(4-lodo-2,5-dimethoxyphenyl) ethanamine (2C-I) I (7518). 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C- I C) (7519). 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C- I N) (7521). 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) I ethanamine (2C-T-4) (7532). MDPV (3,4-Methylenedioxypyrovalerone) (7535)..... I 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- I methoxybenzyl) ethanamine (25B-NBOMe) (7536). 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- I methoxybenzyl) ethanamine (25C-NBOMe) (7537). Methylone (3,4-Methylenedioxy-N-methylcathinone) I (7540). Butylone (7541).................................. I Pentylone (7542)................................. I alpha-pyrrolidinopentiophenone (a-PVP) (7545).... I alpha-pyrrolidinobutiophenone (a-PBP) (7546)..... I AM-694 (1-(5-Fluropentyl)-3-(2- I iodobenzoyl)Indole) (7694). Acetyldihydrocodeine (9051)...................... I Benzylmorphine (9052)............................ I Codeine-N-oxide (9053)........................... I Cyprenorphine (9054)............................. I Desomorphine (9055).............................. I Etorphine (except HCI) (9056).................... I [[Page 73832]] Codeine methylbromide (9070)..................... I Dihydromorphine (9145)........................... I Difenoxin (9168)................................. I Heroin (9200).................................... I Hydromorphinol (9301)............................ I Methyldesorphine (9302).......................... I Methyldihydromorphine (9304)..................... I Morphine methylbromide (9305).................... I Morphine methylsulfonate (9306).................. I Morphine-N-oxide (9307).......................... I Myrophine (9308)................................. I Nicocodeine (9309)............................... I Nicomorphine (9312).............................. I Normorphine (9313)............................... I Pholcodine (9314)................................ I Thebacon (9315).................................. I Acetorphine (9319)............................... I Drotebanol (9335)................................ I Acetylmethadol (9601)............................ I Allylprodine (9602).............................. I Alphacetylmethadol except levo-alphacetyl- I methadol (9603). Alphameprodine (9604)............................ I Alphamethadol (9605)............................. I Benzethidine (9606).............................. I Betacetylmethadol (9607)......................... I Betameprodine (9608)............................. I Betamethadol (9609).............................. I Betaprodine (9611)............................... I Clonitazene (9612)............................... I Dextromoramide (9613)............................ I Diampromide (9615)............................... I Dimenoxadol (9617)............................... I Dimepheptanol (9618)............................. I Dimethylthiambutene (9619)....................... I Dioxaphetyl butyrate (9621)...................... I Dipipanone (9622)................................ I Ethylmethylthiambutene (9623).................... I Etonitazene (9624)............................... I Etoxeridine (9625)............................... I Furethidine (9626)............................... I Ketobemidone (9628).............................. I Levomoramide (9629).............................. I Levophenacylmorphan (9631)....................... I Morpheridine (9632).............................. I Noracymethadol (9633)............................ I Normethadone (9635).............................. I Norpipanone (9636)............................... I Phenadoxone (9637)............................... I Phenoperidine (9641)............................. I Piritramide (9642)............................... I Proheptazine (9643).............................. I Properidine (9644)............................... I Racemoramide (9645).............................. I Trimeperidine (9646)............................. I Phenomorphan (9647).............................. I Propiram (9649).................................. I 1-Methyl-4-phenyl-4-propionoxypiperdine (9661)... I 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperdine I (9663). Tilidine (9750).................................. I Para-Fluorofentanyl (9812)....................... I 3-Methylfentanyl (9813).......................... I Alpha-methylfentanyl (9814)...................... I Acetyl-alpha-methylfentanyl (9815)............... I Beta-hydroxyfentanyl (9830)...................... I Beta-hydroxy-3-methylfentanyl (9831)............. I Alpha-methylthiofentanyl (9832).................. I 3-Methylthiofentanyl (9833)...................... I Thiofentanyl (9835).............................. I Methamphetamine (1105)........................... II Phenmetrazine (1631)............................. II Amobarbital (2125)............................... II Pentobarbital (2270)............................. II Secobarbital (2315).............................. II Glutethimide (2550).............................. II [[Page 73833]] Nabilone (7379).................................. II 1-Phenylcyclohexylamine (7460)................... II Phencyclidine (7471)............................. II Phenylacetone (8501)............................. II 1-Piperidinocyclohexanecarbonitrile (8603)....... II Alphaprodine (9010).............................. II Anileridine (9020)............................... II Etorphine HCI (9059)............................. II Dihydrocodeine (9120)............................ II Diphenoxylate (9170)............................. II Ecgonine (9180).................................. II Ethylmorphine (9190)............................. II Levomethorphan (9210)............................ II Levorphanol (9220)............................... II Isomethadone (9226).............................. II Meperidine (9230)................................ II Meperidine intermediate-A (9232)................. II Meperidine intermediate-B (9233)................. II Meperidine intermediate-C (9234)................. II Metazocine (9240)................................ II Metopon (9260)................................... II Dextropropoxyphene, bulk (non-dosage forms) II (9273). Dihydroetorphine (9334).......................... II Levo-alphacetylmethadol (9648)................... II Noroxymorphone (9668)............................ II Phenazocine (9715)............................... II Piminodine (9730)................................ II Racemethorphan (9732)............................ II Racemorphan (9733)............................... II Alfentanil (9737)................................ II Remifentanil (9739).............................. II Sufentanil (9740)................................ II Carfentanil (9743)............................... II Tapentadol (9780)................................ II Bezitramide (9800)............................... II Moramide-intermediate (9802)..................... II ------------------------------------------------------------------------ The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: November 19, 2015. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2015-29934 Filed 11-24-15; 8:45 am] BILLING CODE 4410-09-P
![73830 Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices
of the Secretary at 202–205–2000. woven selvedge from China to promote for a hearing on the application
General information concerning the administrative efficiency in light of its pursuant to 21 CFR 1301.43 on or before
Commission may also be obtained by decision to conduct a full review with December 28, 2015.
accessing its Internet server (http:// respect to the review on subject imports ADDRESSES: Written comments should
www.usitc.gov). The public record for from Taiwan. A record of the be sent to: Drug Enforcement
this review may be viewed on the Commissioners’ votes, the Administration, Attention: DEA Federal
Commission’s electronic docket (EDIS) Commission’s statement on adequacy, Register Representative/ODXL, 8701
at http://edis.usitc.gov. and any individual Commissioner’s Morrissette Drive, Springfield, Virginia
For further information concerning statements will be available from the
22152. Request for hearings should be
the conduct of this review and rules of Office of the Secretary and at the
sent to: Drug Enforcement
general application, consult the Commission’s Web site.
Commission’s Rules of Practice and Administration, Attention: Hearing
Authority: These reviews are being Clerk/LJ, 8701 Morrissette Drive,
Procedure, part 201, subparts A through conducted under authority of title VII of the
E (19 CFR part 201), and part 207, Springfield, Virginia 22152.
Tariff Act of 1930; this notice is published
subparts A, D, E, and F (19 CFR part pursuant to section 207.62 of the SUPPLEMENTARY INFORMATION: The
207). Commission’s rules. Attorney General has delegated her
SUPPLEMENTARY INFORMATION: On By order of the Commission. authority under the Controlled
November 6, 2015, the Commission Issued: November 19, 2015. Substances Act to the Administrator of
determined that it should proceed to Lisa R. Barton, the Drug Enforcement Administration
full reviews in the subject five-year (DEA), 28 CFR 0.100(b). Authority to
Secretary to the Commission.
reviews pursuant to section 751(c) of the exercise all necessary functions with
[FR Doc. 2015–29938 Filed 11–24–15; 8:45 am]
Tariff Act of 1930 (19 U.S.C. 1675(c)). respect to the promulgation and
BILLING CODE 7020–02–P
The Commission found that the implementation of 21 CFR part 1301,
domestic interested party group incident to the registration of
response to its notice of institution (80 manufacturers, distributors, dispensers,
DEPARTMENT OF JUSTICE importers, and exporters of controlled
FR 46048, August 3, 2015) was adequate
and that the respondent interested party substances (other than final orders in
Drug Enforcement Administration
group with respect to the review on connection with suspension, denial, or
subject imports from Taiwan was [Docket No. DEA–392] revocation of registration) has been
adequate, and decided to conduct a full redelegated to the Deputy Assistant
Importer of Controlled Substances Administrator of the DEA Office of
review of the antidumping duty order
Application: VHG Labs DBA LGC Diversion Control (‘‘Deputy Assistant
on narrow woven ribbons with woven
Standards Warehouse Administrator’’) pursuant to section. 7
selvedge from Taiwan. Although the
Commission received a response to its ACTION: Notice of application. of 28 CFR part 0, appendix to subpart
notice of institution from Chinese R.
respondent interested parties, the DATES: Registered bulk manufacturers of In accordance with 21 CFR
Commission found that the respondent the affected basic classes, and 1301.34(a), this is notice that on
interested party group response with applicants therefore, may file written December 03, 2014, VHG Labs DBA LGC
respect to the reviews on subject comments on or objections to the Standards Warehouse, 3 Perimeter
imports from China was inadequate.1 issuance of the proposed registration in Road, Manchester, New Hampshire
However, the Commission determined accordance with 21 CFR 1301.34(a) on 03103 applied to be registered as an
to conduct full reviews concerning the or before December 28, 2015. Such importer of the following basic classes
orders on narrow woven ribbons with persons may also file a written request of controlled substances:
Controlled substance Schedule
3-Fluoro-N-methylcathinone (3-FMC) (1233) .............................................................................................................................................. I
Cathinone (1235) ......................................................................................................................................................................................... I
Methcathinone (1237) .................................................................................................................................................................................. I
4-Fluoro-N-methylcathinone (4-FMC) (1238) .............................................................................................................................................. I
Pentedrone (a-methylaminovalerophenone) (1246) .................................................................................................................................... I
Mephedrone (4-Methyl-N-methylcathinone) (1248) .................................................................................................................................... I
4-Methyl-N-ethylcathinone (4-MEC) (1249) ................................................................................................................................................ I
Naphyrone (1258) ........................................................................................................................................................................................ I
N-Ethylamphetamine (1475) ........................................................................................................................................................................ I
N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I
Fenethylline (1503) ...................................................................................................................................................................................... I
4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I
Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... I
Methaqualone (2565) .................................................................................................................................................................................. I
Mecloqualone (2572) ................................................................................................................................................................................... I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250) ................................................................................................................... I
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) Indole) (7008) ................................................................. I
5-Fluoro-UR-144 and XLR11 [1-(5-Flouro-pentyl)-1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl) methanone (7011) ............................. I
tkelley on DSK3SPTVN1PROD with NOTICES
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl) -1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) (7012) ..................................... I
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) ....................................................................................................................................... I
ADB-PINACA (N-1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) (7035) ................................................... I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048) ............................................................................... I
1 Vice Chairman Pinkert and Commissioner respondent group responses were adequate and
Williamson determined that the Chinese voted for full reviews.
VerDate Sep<11>2014 19:15 Nov 24, 2015 Jkt 238001 PO 00000 Frm 00133 Fmt 4703 Sfmt 4703 E:\FR\FM\25NON1.SGM 25NON1](https://thefederalregister.org/doc/80_FR_74057/page/1.svg)
![Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices 73831
Controlled substance Schedule
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) Indole) (7081) ................................................................................................................... I
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) ...................................................................................... I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) (7118) ............................................................................................... I
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)Indole) (7122) ....................................................................................................................... I
UR-144 (1-Pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone (7144) ................................................................................ I
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) (7173) ........................................................................................................................................ I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) (7200) ........................................................................................................... I
AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) Indole) (7201) ...................................................................................................................... I
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)Indole) (7203) ........................................................................................................................ I
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) (7222) .................................................................................................................. I
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) (7225) .............................................................................................. I
Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I
Ibogaine (7260) ........................................................................................................................................................................................... I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) .................................................................................. I
CP-47497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298) ............................................................. I
Lysergic acid diethylamide (7315) ............................................................................................................................................................... I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (7348) ................................................................................................................ I
Marihuana (7360) ........................................................................................................................................................................................ I
Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I
Parahexyl (7374) ......................................................................................................................................................................................... I
Mescaline (7381) ......................................................................................................................................................................................... I
2-(4-Elthylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2) (7385) ............................................................................................................. I
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I
4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I
4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I
4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)Indole (7398) ......................................................................................................................... I
2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ I
3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) .................................................................................................................................. I
N-Hydroxy-3,4-methylenedioxyamphetaimine (7402) ................................................................................................................................. I
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I
4-Methoxyamphetamine (7411) ................................................................................................................................................................... I
Peyote (7415) .............................................................................................................................................................................................. I
5-Methoxy-N-N-dimethyltryptamine (7431) ................................................................................................................................................. I
Alpha-methyltryptamine (7432) ................................................................................................................................................................... I
Bufotenine (7433) ........................................................................................................................................................................................ I
Diethyltryptamine (7434) ............................................................................................................................................................................. I
Dimethyltryptamine (7435) .......................................................................................................................................................................... I
Psilocybin (7437) ......................................................................................................................................................................................... I
Psilocyn (7438) ............................................................................................................................................................................................ I
5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. I
N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... I
1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (7473) .............................................................................................................................................. I
N-Ethyl-3-piperidyl benzilate (7482) ............................................................................................................................................................ I
N-Methyl-3-piperidyl benzilate (7484) ......................................................................................................................................................... I
N-Benzylpiperazine (7493) .......................................................................................................................................................................... I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) (7498) ...................................................................................................................... I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) (7508) ................................................................................................................... I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) (7509) ...................................................................................................................... I
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) (7517) .................................................................................................................................. I
2-(4-lodo-2,5-dimethoxyphenyl) ethanamine (2C-I) (7518) ......................................................................................................................... I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) (7519) ................................................................................................................... I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) (7521) ..................................................................................................................... I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4) (7532) ...................................................................................................... I
MDPV (3,4-Methylenedioxypyrovalerone) (7535) ....................................................................................................................................... I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) (7536) ..................................................................... I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) (7537) ..................................................................... I
Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) ....................................................................................................................... I
Butylone (7541) ........................................................................................................................................................................................... I
Pentylone (7542) ......................................................................................................................................................................................... I
alpha-pyrrolidinopentiophenone (a-PVP) (7545) ......................................................................................................................................... I
alpha-pyrrolidinobutiophenone (a-PBP) (7546) ........................................................................................................................................... I
tkelley on DSK3SPTVN1PROD with NOTICES
AM-694 (1-(5-Fluropentyl)-3-(2-iodobenzoyl)Indole) (7694) ....................................................................................................................... I
Acetyldihydrocodeine (9051) ....................................................................................................................................................................... I
Benzylmorphine (9052) ............................................................................................................................................................................... I
Codeine-N-oxide (9053) .............................................................................................................................................................................. I
Cyprenorphine (9054) .................................................................................................................................................................................. I
Desomorphine (9055) .................................................................................................................................................................................. I
Etorphine (except HCI) (9056) .................................................................................................................................................................... I
VerDate Sep<11>2014 19:15 Nov 24, 2015 Jkt 238001 PO 00000 Frm 00134 Fmt 4703 Sfmt 4703 E:\FR\FM\25NON1.SGM 25NON1](https://thefederalregister.org/doc/80_FR_74057/page/2.svg)
![Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices 73833
Controlled substance Schedule
Nabilone (7379) ........................................................................................................................................................................................... II
1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II
Phencyclidine (7471) ................................................................................................................................................................................... II
Phenylacetone (8501) ................................................................................................................................................................................. II
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ II
Alphaprodine (9010) .................................................................................................................................................................................... II
Anileridine (9020) ........................................................................................................................................................................................ II
Etorphine HCI (9059) .................................................................................................................................................................................. II
Dihydrocodeine (9120) ................................................................................................................................................................................ II
Diphenoxylate (9170) .................................................................................................................................................................................. II
Ecgonine (9180) .......................................................................................................................................................................................... II
Ethylmorphine (9190) .................................................................................................................................................................................. II
Levomethorphan (9210) .............................................................................................................................................................................. II
Levorphanol (9220) ..................................................................................................................................................................................... II
Isomethadone (9226) .................................................................................................................................................................................. II
Meperidine (9230) ....................................................................................................................................................................................... II
Meperidine intermediate-A (9232) ............................................................................................................................................................... II
Meperidine intermediate-B (9233) ............................................................................................................................................................... II
Meperidine intermediate-C (9234) ............................................................................................................................................................... II
Metazocine (9240) ....................................................................................................................................................................................... II
Metopon (9260) ........................................................................................................................................................................................... II
Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II
Dihydroetorphine (9334) .............................................................................................................................................................................. II
Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II
Noroxymorphone (9668) .............................................................................................................................................................................. II
Phenazocine (9715) .................................................................................................................................................................................... II
Piminodine (9730) ....................................................................................................................................................................................... II
Racemethorphan (9732) .............................................................................................................................................................................. II
Racemorphan (9733) ................................................................................................................................................................................... II
Alfentanil (9737) .......................................................................................................................................................................................... II
Remifentanil (9739) ..................................................................................................................................................................................... II
Sufentanil (9740) ......................................................................................................................................................................................... II
Carfentanil (9743) ........................................................................................................................................................................................ II
Tapentadol (9780) ....................................................................................................................................................................................... II
Bezitramide (9800) ...................................................................................................................................................................................... II
Moramide-intermediate (9802) .................................................................................................................................................................... II
The company plans to import DEPARTMENT OF JUSTICE Illinois. Id. The Order alleged that
analytical reference standards for Registrant’s registration expires by its
distribution to its customers for research Drug Enforcement Administration terms on January 31, 2018. Id.
and analytical purposes. Placement of The Order further alleged that
William Mikaitis, M.D.; Decision and ‘‘[e]ffective March 5, 2015, the State of
these drug codes onto the company’s
Order Illinois, Department of Financial and
registration does not translate into
automatic approval of subsequent Professional Regulation (IDFPR),
On July 23, 2015, the Deputy
permit applications to import controlled Division of Professional Regulation,
Assistant Administrator, Office of
issued an Order in which the IDFPR
substances. Diversion Control, Drug Enforcement temporarily suspended [his] Illinois
Approval of permit applications will Administration (DEA), issued an Order [P]hysician and [S]urgeon [L]icense and
occur only when the registrant’s to Show Cause to William Mikaitis, [his] controlled substance licenses’’ and
business activity is consistent with what M.D. (Registrant), of Lockport, Illinois. that ‘‘[t]his Order remains in effect.’’ Id.
is authorized under 21 U.S.C. 952(a)(2). The Show Cause Order proposed the The Show Cause Order thus asserted
Authorization will not extend to the revocation of Registrant’s DEA that ‘‘DEA must revoke [his] registration
Certificate of Registration AM1585770, based upon [his] lack of authority to
import of FDA approved or non-
and the denial of any applications to handle controlled substances in the
approved finished dosage forms for
renew or modify the registration as well State of Illinois.’’ Id. (citing 21 U.S.C.
commercial sale.
as any other applications for a DEA 802(21), 823(f) and 824(a)(3)).
Dated: November 19, 2015. registration, on the ground that he The Show Cause Order also notified
Louis J. Milione, ‘‘do[es] not have authority to practice Registrant of his right to request a
Deputy Assistant Administrator. medicine or handle controlled hearing on the allegations or to submit
[FR Doc. 2015–29934 Filed 11–24–15; 8:45 am]
substances in Illinois, the [S]tate in a written statement in lieu of a hearing,
which [he] is registered with the DEA.’’ the procedure for electing either option,
BILLING CODE 4410–09–P
Show Cause Order at 1 (citing 21 U.S.C. and the consequence for failing to elect
tkelley on DSK3SPTVN1PROD with NOTICES
823(f) and 824(a)(3)). either option. Id. at 2 (citing 21 CFR
The Show Cause Order alleged that 1301.43).
Registrant is registered with the DEA as On July 30, 2015, a Diversion
a practitioner authorized to handle Investigator met Registrant at the office
controlled substances in Schedules II of his attorney and personally served
through V at the registered address of the Show Cause Order on him. See GX
1206 E. 9th St., Suite 210, Lockport, 5 (Affidavit of DI). The Government
VerDate Sep<11>2014 19:15 Nov 24, 2015 Jkt 238001 PO 00000 Frm 00136 Fmt 4703 Sfmt 4703 E:\FR\FM\25NON1.SGM 25NON1](https://thefederalregister.org/doc/80_FR_74057/page/4.svg)
Document Created: 2018-03-01 11:14:31
Document Modified: 2018-03-01 11:14:31
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before December 28, 2015. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before December 28, 2015. | |
| FR Citation | 80 FR 73830 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR